APA (7th ed.) Citation

HG, O., A, M., G, S., TR, C., S, D., S, T., . . . S, K. (2020). Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week. Annals of clinical microbiology and antimicrobials, 19(1), 3. https://doi.org/10.1186/s12941-020-0345-6

Chicago Style (17th ed.) Citation

HG, Ouedraogo, et al. "Pharmacokinetics of Plasma Lopinavir and Ritonavir in Tuberculosis-HIV Co-infected African Adult Patients Also Receiving Rifabutin 150 or 300 mg Three Times Per Week." Annals of Clinical Microbiology and Antimicrobials 19, no. 1 (2020): 3. https://doi.org/10.1186/s12941-020-0345-6.

MLA (9th ed.) Citation

HG, Ouedraogo, et al. "Pharmacokinetics of Plasma Lopinavir and Ritonavir in Tuberculosis-HIV Co-infected African Adult Patients Also Receiving Rifabutin 150 or 300 mg Three Times Per Week." Annals of Clinical Microbiology and Antimicrobials, vol. 19, no. 1, 2020, p. 3, https://doi.org/10.1186/s12941-020-0345-6.